Cargando…
The value of MRI in management of endometrial hyperplasia with atypia
BACKGROUND: The value of the magnetic resonance imaging (MRI) in the assessment of women with endometrial hyperplasia and its role in diagnosis of myometrial invasion or coexistence of cancer is not known. This study aimed to evaluate the accuracy and usefulness of MRI in the management of patients...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011375/ https://www.ncbi.nlm.nih.gov/pubmed/32041614 http://dx.doi.org/10.1186/s12957-020-1811-5 |
_version_ | 1783496056817844224 |
---|---|
author | Natarajan, Purushothaman Vinturache, Angela Hutson, Richard Nugent, David Broadhead, Timothy |
author_facet | Natarajan, Purushothaman Vinturache, Angela Hutson, Richard Nugent, David Broadhead, Timothy |
author_sort | Natarajan, Purushothaman |
collection | PubMed |
description | BACKGROUND: The value of the magnetic resonance imaging (MRI) in the assessment of women with endometrial hyperplasia and its role in diagnosis of myometrial invasion or coexistence of cancer is not known. This study aimed to evaluate the accuracy and usefulness of MRI in the management of patients diagnosed on endometrial biopsy with complex endometrial hyperplasia with atypia (CEHA). METHODS: A retrospective study of 86 cases diagnosed with endometrial hyperplasia with atypia on the initial endometrial biopsy in a tertiary university teaching hospital between 2010 and 2015 was carried out. The MRI accuracy in predicting malignant changes and influence the clinical management was compared among women who had either pelvic MRI, transvaginal ultrasound (TVUS), or no additional imagistic studies. RESULTS: MRI was performed in 24 (28%) and TVUS in 11 (13%)cases, while 51 (59%) women had no additional imagistic studies. In the group of women with no imaging studies, 26/51 (51%) were surgically treated and 8/26 (31%) were diagnosed with endometrial cancer (EEC) stage 1a. In the group of women who had TVUS, 5/11 (45%) were surgically treated and none was diagnosed with EEC. In the group of women who underwent an MRI examination, 20/24 (83%) were surgically treated. Among these, 11/20 (55%) were diagnosed with EEC, 7 had EEC stage 1a, and 4 had EEC stage 1b. Although MRI was able to identify malignant changes with a good sensitivity (91.7%), it had a low specificity in characterisation of malignant transformation (8%). MRI correctly identified 31% of the stage 1a and 33% of the stage 1b endometrial cancer. CONCLUSION: In this study, we found a potential diagnostic value of MRI for identifying malignant transformation in patients with CEHA. However, pelvic MRI has a rather weak predictive value of myometrial invasion in women with CEHA and concurrent EEC. The diagnostic and therapeutic benefits of MRI assessment in patients with CEHA need further validation. |
format | Online Article Text |
id | pubmed-7011375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70113752020-02-14 The value of MRI in management of endometrial hyperplasia with atypia Natarajan, Purushothaman Vinturache, Angela Hutson, Richard Nugent, David Broadhead, Timothy World J Surg Oncol Research BACKGROUND: The value of the magnetic resonance imaging (MRI) in the assessment of women with endometrial hyperplasia and its role in diagnosis of myometrial invasion or coexistence of cancer is not known. This study aimed to evaluate the accuracy and usefulness of MRI in the management of patients diagnosed on endometrial biopsy with complex endometrial hyperplasia with atypia (CEHA). METHODS: A retrospective study of 86 cases diagnosed with endometrial hyperplasia with atypia on the initial endometrial biopsy in a tertiary university teaching hospital between 2010 and 2015 was carried out. The MRI accuracy in predicting malignant changes and influence the clinical management was compared among women who had either pelvic MRI, transvaginal ultrasound (TVUS), or no additional imagistic studies. RESULTS: MRI was performed in 24 (28%) and TVUS in 11 (13%)cases, while 51 (59%) women had no additional imagistic studies. In the group of women with no imaging studies, 26/51 (51%) were surgically treated and 8/26 (31%) were diagnosed with endometrial cancer (EEC) stage 1a. In the group of women who had TVUS, 5/11 (45%) were surgically treated and none was diagnosed with EEC. In the group of women who underwent an MRI examination, 20/24 (83%) were surgically treated. Among these, 11/20 (55%) were diagnosed with EEC, 7 had EEC stage 1a, and 4 had EEC stage 1b. Although MRI was able to identify malignant changes with a good sensitivity (91.7%), it had a low specificity in characterisation of malignant transformation (8%). MRI correctly identified 31% of the stage 1a and 33% of the stage 1b endometrial cancer. CONCLUSION: In this study, we found a potential diagnostic value of MRI for identifying malignant transformation in patients with CEHA. However, pelvic MRI has a rather weak predictive value of myometrial invasion in women with CEHA and concurrent EEC. The diagnostic and therapeutic benefits of MRI assessment in patients with CEHA need further validation. BioMed Central 2020-02-10 /pmc/articles/PMC7011375/ /pubmed/32041614 http://dx.doi.org/10.1186/s12957-020-1811-5 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Natarajan, Purushothaman Vinturache, Angela Hutson, Richard Nugent, David Broadhead, Timothy The value of MRI in management of endometrial hyperplasia with atypia |
title | The value of MRI in management of endometrial hyperplasia with atypia |
title_full | The value of MRI in management of endometrial hyperplasia with atypia |
title_fullStr | The value of MRI in management of endometrial hyperplasia with atypia |
title_full_unstemmed | The value of MRI in management of endometrial hyperplasia with atypia |
title_short | The value of MRI in management of endometrial hyperplasia with atypia |
title_sort | value of mri in management of endometrial hyperplasia with atypia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011375/ https://www.ncbi.nlm.nih.gov/pubmed/32041614 http://dx.doi.org/10.1186/s12957-020-1811-5 |
work_keys_str_mv | AT natarajanpurushothaman thevalueofmriinmanagementofendometrialhyperplasiawithatypia AT vinturacheangela thevalueofmriinmanagementofendometrialhyperplasiawithatypia AT hutsonrichard thevalueofmriinmanagementofendometrialhyperplasiawithatypia AT nugentdavid thevalueofmriinmanagementofendometrialhyperplasiawithatypia AT broadheadtimothy thevalueofmriinmanagementofendometrialhyperplasiawithatypia AT natarajanpurushothaman valueofmriinmanagementofendometrialhyperplasiawithatypia AT vinturacheangela valueofmriinmanagementofendometrialhyperplasiawithatypia AT hutsonrichard valueofmriinmanagementofendometrialhyperplasiawithatypia AT nugentdavid valueofmriinmanagementofendometrialhyperplasiawithatypia AT broadheadtimothy valueofmriinmanagementofendometrialhyperplasiawithatypia |